sb 203580 has been researched along with Uveitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belfort, R; Belfort, RN; Bombardieri, CR; Commodaro, AG; de Camargo, MM; Guedes, PM; Hamassaki, DE; Peron, JP; Rizzo, LV; Saito, KC | 1 |
1 other study(ies) available for sb 203580 and Uveitis
Article | Year |
---|---|
p38{alpha} MAP kinase controls IL-17 synthesis in vogt-koyanagi-harada syndrome and experimental autoimmune uveitis.
Topics: Adolescent; Adult; Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Disease Models, Animal; Enzyme Inhibitors; Female; Fetal Blood; Flow Cytometry; Humans; Imidazoles; Interleukin-17; Lymph Nodes; Male; Mice; Middle Aged; Mitogen-Activated Protein Kinase 14; Pyridines; Ribosomal Protein S6 Kinases, 90-kDa; RNA, Small Interfering; Spleen; Uveitis; Uveomeningoencephalitic Syndrome; Young Adult | 2010 |